NCT04351906View on ClinicalTrials.gov

Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 3, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
ARDSHypercapnic Respiratory FailureAKI
Interventions
DEVICE

ECCO2R

ECCO2R integrated into the multiFiltrate device

Trial Locations (1)

35382

University Hospital Giessen and Marburg, Giessen, Giessen

All Listed Sponsors
lead

University of Giessen

OTHER

NCT04351906 - Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter